Xencor (XNCR) appoints Todd Simpson to Board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/20/2026

1. MMM
2. GRMN
3. STLD
4. META
5. HBCP
6. WRB
7. TSLA
8. IT
9. SPY
10. ZION

Go back to Xencor (XNCR) appoints Todd Simpson to Board

Xencor Appoints Todd Simpson to Board of Directors

March 13, 2025 4:01 PM EDT

PASADENA, Calif.--(BUSINESS WIRE)-- Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, today announced the appointment of Todd Simpson to its board of directors. Mr. Simpson has more than 40 years of experience in chief financial officer (CFO) roles at multiple biopharmaceutical companies and in public accounting. Most recently he served as CFO at Seagen Inc. through its acquisition in 2023.

Mr. Simpson is an accomplished finance and operations executive with broad experience in corporate strategy, and he played a key role in... More